Uttara Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.35 Cr
as on 02-07-2024
- Satisfied Charges ₹ 7.60 Cr
as on 02-07-2024
- Revenue %
(FY 2020)
- Profit -49.81%
(FY 2020)
- Ebitda -49.81%
(FY 2020)
- Net Worth -0.00%
(FY 2020)
- Total Assets -0.06%
(FY 2020)
About Uttara Biosciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.35 Cr. The company has closed loans amounting to ₹7.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Barkat Quadri and Sunil Gadkari serve as directors at the Company.
- CIN/LLPIN
U24230PN2007PTC130916
- Company No.
130916
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Uttara Biosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Barkat Quadri  | Director | 27-Jul-2022 | Current |
| Sunil Gadkari | Director | 27-Jul-2022 | Current |
Financial Performance and Corporate Structure Insights of Uttara Biosciences.
Uttara Biosciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 49.81% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uttara Biosciences?
In 2020, Uttara Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uttara Bakers Private LimitedActive 12 years 7 monthsBarkat Quadri and Sunil Gadkari are mutual person
Venkateshwara Poultry Breeding Farms Private LimitedActive 13 years 2 monthsBarkat Quadri and Sunil Gadkari are mutual person
- Padmavati Marbles Private LimitedActive 11 years 6 months
Barkat Quadri and Sunil Gadkari are mutual person
- Uttara Masala Products Private LimitedActive 20 years 11 months
Barkat Quadri and Sunil Gadkari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 Aug 2008 | ₹3.35 Cr | Open |
Axis Bank Limited Creation Date: 15 Jun 2012 | ₹5.00 Cr | Satisfied |
Indusind Bank Limited Creation Date: 22 Feb 2008 | ₹2.60 Cr | Satisfied |
How Many Employees Work at Uttara Biosciences?
Unlock and access historical data on people associated with Uttara Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uttara Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uttara Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
